AOD-9604 + CJC-1295 (No DAC) Stack

Fat loss + GH optimization. AOD-9604 targets lipolysis while CJC-1295 elevates GH for body composition.

The combination of AOD-9604 and CJC-1295 (No DAC) represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.

AOD-9604 primarily acts via modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects., while CJC-1295 (No DAC) complements this by short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.